Moneycontrol PRO

business

Two pharma stocks that can improve health of your portfolio

Ranbaxy and Cipla were at 52 week highs on Monday. Kour expects Cipla to perform well going ahead. She is bullish on this stock; however, she is cautious on Ranbaxy.

first published: Sep 4, 2012 01:04 pm

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347